Shock after acute myocardial infarction. A clinical and hemodynamic profile.
D000208:Acute Disease; D000328:Adult; D000367:Age Factors; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D001002:Anuria / Q000209:etiology; D001145:Arrhythmias, Cardiac / Q000150:complications; D001161:Arteriosclerosis / Q000473:pathology; D001219:Aspartate Aminotransferases / Q000097:blood; D001344:Autopsy; D001794:Blood Pressure; D003331:Coronary Vessels / Q000473:pathology; D005260:Female; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications* / Q000473:pathology; D009461:Neurologic Manifestations; D011654:Pulmonary Edema / Q000209:etiology; D012737:Sex Factors; D012770:Shock, Cardiogenic / Q000150:complications / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology* / Q000401:mortality / Q000503:physiopathology; D012867:Skin / Q000503:physiopathology; D013997:Time Factors; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase